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        Introduction 
  Our understanding of the mechanisms regulating insulin secre-
tion at the organismal level improved greatly recently with the 
identifi  cation of several novel hormones (  Herman and Kahn, 
2006  ;   Gesta et al., 2007  ;   Lee et al., 2007  ). It was shown, for in-
stance, that skeleton acts as an endocrine regulator of energy 
metabolism through the osteoblast-specifi  c secreted molecule 
osteocalcin that favors insulin secretion by      cells, insulin sen-
sitivity in fat, liver, and muscle, and energy expenditure (  Lee et al., 
2007  ). Although osteocalcin bioactivity is regulated by at least 
two gene products within the osteoblast, Esp and    -carboxylase 
(  B  ü  gel, 2008  ), it remains unknown whether extracellular cues 
regulate its secretion or function. 
  In contrast to osteocalcin, leptin inhibits insulin secretion 
in part through a direct effect on      cells (  Covey et al., 2006  ; 
  Morioka et al., 2007  ) and, as is the case for most of its func-
tions, in part through indirect mechanisms (  Friedman and 
Halaas, 1998 ;  Kieffer and Habener, 2000 ). Leptin affects osteo-
blast functions, raising the testable hypothesis that it could in-
hibit insulin secretion by decreasing osteocalcin activity (  Ducy 
et al., 2000  ;   Takeda et al., 2002  ). 
  In this study, we show that one important mechanism 
whereby leptin inhibits insulin secretion is by inhibiting the bio-
activity of osteocalcin. These results provide in vivo evidence of 
the importance of the cross talk existing between osteoblasts 
and adipocytes in glucose homeostasis. 
  Results and discussion 
  Regulation of insulin secretion by leptin 
  The fact that leptin and osteocalcin exert opposite functions on 
insulin secretion prompted us to test whether they act indepen-
dently of each other or not. To avoid the confounding issue of 
insulin resistance, we analyzed insulin secretion in leptin-
 defi  cient (  ob/ob  ) mice at birth and 1 and 2 wk of age because at 
those ages body weight, abdominal and total fat mass, triglyc-
eride level, and insulin sensitivity are not altered by the absence 
T
he osteoblast-secreted molecule osteocalcin favors in-
sulin secretion, but how this function is regulated in 
vivo by extracellular signals is for now unknown. In this 
study, we show that leptin, which instead inhibits insulin se-
cretion, partly uses the sympathetic nervous system to fulﬁ  ll 
this function. Remarkably, for our purpose, an osteoblast-
speciﬁ  c ablation of sympathetic signaling results in a leptin-
dependent hyperinsulinemia. In osteoblasts, sympathetic tone 
stimulates expression of   Esp  , a gene inhibiting the activity of 
osteocalcin, which is an insulin secretagogue. Accordingly, 
  Esp   inactivation doubles hyperinsulinemia and delays 
glucose intolerance in   ob/ob   mice, whereas   Osteocalcin   
inactivation halves their hyperinsulinemia. By showing that 
leptin inhibits insulin secretion by decreasing osteocalcin 
bioactivity, this study illustrates the importance of the rela-
tionship existing between fat and skeleton for the regulation 
of glucose homeostasis.
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crease insulin secretion by   ob/ob   islets (  Fig. 1, L and M  ). This 
result supports the notion that this hormone acts directly on 
     cells to regulate insulin secretion; however, the decrease ob-
served was too modest to explain why the absence of leptin 
would result in a 2.5-fold increase in circulating insulin levels 
(  Fig. 1 B  ). In the face of these results, we asked whether islets 
isolated from mice harboring an activating mutation in the 
leptin receptor (  L/L   mice;   Bj  ö  rnholm et al., 2007  ) might be a 
better tool to uncover a more signifi  cant direct effect of leptin on 
     cells.  In  this study, again we observed only a modest decrease 
in insulin secretion after leptin treatment (  Fig. 1 N  ). The marked 
increase in insulin secretion by high glucose concentration 
served as an internal positive control and indicated that the 
islets used in all of these experiments were in good condition. 
Collectively, data obtained using islets isolated from WT,   ob/ob , 
and   L/L   mice verifi  ed that leptin acts locally on      cells to inhibit 
insulin secretion but were also consistent with the hypothesis 
that in addition to this direct effect, leptin may use indirect 
mechanisms to regulate insulin secretion. 
  Leptin-dependent sympathetic regulation 
of insulin secretion 
  Given what is known about the mediation of most of its func-
tions, the aforementioned results prompted us to ask whether 
leptin also uses a neuronal relay to inhibit insulin secretion. 
Thus, we crossed mice harboring a fl  oxed allele of the leptin re-
ceptor gene   Lepr   ( Lepr-fl  ox/fl  ox  ) with   Synapsin-Cre   transgenic 
mice to remove the leptin receptor in all neurons (  van de Wall 
et al., 2008  ). 1-mo-old   Synapsin-Cre ; Lepr-fl  ox/fl  ox   ( Lepr  syn  
   /     ) 
mice had a normal body weight but harbored a signifi  cant in-
crease in serum insulin levels, indicating that in vivo there is 
a signifi  cant neuronal contribution to the leptin regulation of in-
sulin secretion (  Fig. 1 O   and Fig. S1 M). 
  We noted that in   Lepr  syn  
   /       mice, sympathetic tone, as 
measured by   Ucp1   expression in brown fat and serum levels 
of epinephrine and norepinephrine, was low (  Fig. 2, A  –  C  ). 
This decrease, similar to the one observed in   ob/ob   mice, led 
us to ask whether the sympathetic tone could be a mediator of 
the leptin-dependent neuronal regulation of insulin secretion 
(  Berthoud and Jeanrenaud, 1979  ). WT,   ob/ob  , and adipocyte-
defi  cient newborn pups were treated for 2 wk with sympatho-
mimetics acting through   -adrenergic receptors (isoproterenol) 
or through the Adr   2  (clonidine)  or Adr  1  (phenylephrine)  re-
ceptors. Neither phenylephrine nor clonidine affected serum 
insulin levels in any of the mouse models tested; in contrast, 
isoproterenol used at a moderate dose (3 mg/kg) signifi  cantly 
decreased circulating insulin levels in   ob/ob   and  adipocyte-
defi  cient mice (  Fig. 2, D and E  ). Isoproterenol increased   Ucp1  
expression in brown fat, supporting the notion that there was 
an increase in sympathetic tone following this treatment ( Fig. 2 F ). 
Isoproterenol did not affect circulating insulin in WT mice, 
probably because it was used at a dose that did not cause a mas-
sive increase in sympathetic tone. Indeed,   Ucp1   expression 
was not signifi  cantly increased in WT mice by isoproterenol 
(  Fig. 2 F  ). Collectively, these observations establish that the 
sympathetic tone acting through     -adrenergic receptors regu-
lates insulin secretion. 
of leptin (  Fig. 1 A   and Fig. S1, A  –  D, available at http://www
.jcb.org/cgi/content/full/jcb.200809113/DC1). 
  In 2-wk-old   ob/ob   mice serum, insulin levels were 2.5-fold 
higher than in wild-type (WT) littermates, resulting in a   >  30% 
decrease of blood glucose levels after feeding. Remarkably, hyper-
insulinemia and low blood glucose levels were also present in 
newborn and 1-wk-old  ob/ob  mice ( Fig. 1, B and C ). To understand 
how this marked hyperinsulinemia develops in mice that are 
otherwise metabolically normal, we studied islet gene expres-
sion and     -cell proliferation in WT and   ob/ob   mice.  Expression 
of the   Insulin   genes and of   Glucokinase  , a central component of 
the glucose-sensing machinery of      cells (  Grupe et al., 1995  ), was 
increased 50% and 140%, respectively, in   ob/ob   mice (  Fig. 1 D  ), 
at least partly explaining the aforementioned increased insulin 
levels. Serum c-peptide levels were increased 2.5-fold in   ob/ob  
mice (Fig. S1 E). There was also a small but detectable and 
reproducible increase in insulin content in   ob/ob   pancreata 
(Fig. S1 F). In addition, expression of   Cdk4  , a gene favoring 
    -cell proliferation in vivo (  Rane et al., 1999  ), was up-regulated 
50% in   ob/ob   islets, and Ki67 immunostaining showed a signif-
icant increase in     -cell proliferation in   ob/ob   compared  with 
WT mice (  Fig. 1, D and E  ). Undetectable increases in    -cell 
area and     -cell mass (Fig. S1, G and H) indicate that the ab-
sence of leptin affects circulating insulin levels primarily by 
regulating insulin expression and secretion in addition to the 
possibility of changes of cell survival. Nevertheless, these re-
sults establish that leptin is a physiological regulator of serum 
insulin levels independent of the infl  uence it may have on insu-
lin sensitivity. 
  We asked whether similar abnormalities were present 
in mice lacking adipocytes altogether. 2-wk-old adipocyte-
 defi  cient mice were also markedly hyperinsulinemic and had a 
signifi  cant drop in blood glucose levels; this hyperinsulinemia 
was also observed at birth (  Fig. 1, F and G  ; and Fig. S1, I and J). 
Expression of   Insulin ,   Glucokinase  , and   Cdk4   was  up-regulated 
to the same extent in islets of adipocyte-defi  cient and   ob/ob  
mice (  Fig. 1 H  ), and insulin content was signifi  cantly increased 
in islets of adipocyte-defi  cient mice (Fig. S1 K).    -cell  prolif-
eration, area, and mass were all signifi  cantly increased in adi-
pocyte-defi  cient mice (  Fig. 1, I  –  K  ; and Fig. S1 L). Collectively, 
and although insulin resistance may have favored    -cell  prolif-
eration in the adipocyte-defi  cient mice, the data presented here 
show that hyperinsulinemia and lower blood glucose levels 
precede the appearance of obesity and hyperglycemia in   ob/ob  
and adipocyte-defi  cient mice, respectively, and can be ascribed 
in both cases to an increase in   Insulin   and   Glucokinase   expres-
sion and, to a lesser extent, to an increase in    -cell  proliferation. 
More severe hyperinsulinemia in adipocyte-defi  cient mice than 
in ob/ob mice indicates that in addition to leptin defi  ciency, 
other mechanisms affect insulin secretion in the former model. 
  Multiple mechanisms contribute to leptin 
regulation of insulin secretion 
  Next, we studied leptin infl  uence on isolated islets. When using 
WT islets cultured in low or high glucose concentration, we 
failed to observe a decrease in the amount of insulin secreted in 
the medium after leptin treatment. In contrast, leptin did de-1237 LEPTIN REGULATION OF INSULIN SECRETION   • Hinoi et al. 
(Fig. S2, F  –  H). This was specifi  c of   Adr   2    deletion  because 
serum insulin levels were normal in  Adr   1 
   /      and  Adr   2A 
   /      mice 
(unpublished data).   Adr   2 osb  
   /       mice also had an 80  –  150% in-
crease in   Insulin   and   Glucokinase   expression and exhibited 
postprandial low blood glucose levels (  Fig. 2, I and J  ), and   Cdk4  
expression was increased 50% in   Adr   2 osb  
   /       mice (  Fig. 2 J  ). 
It is worthwhile to note that these abnormalities were similar to 
the ones observed in   ob/ob   mice (compare with   Fig. 1 D  ). 
  If sympathetic signaling in osteoblasts and leptin are in 
the same genetic pathway, genetic epistasis predicts that mice 
heterozygous for  Adr   2   defi  ciency and  Leptin  defi  ciency should 
harbor the same defect in insulin secretion than the one ob-
served in   Adr   2 osb  
   /       and   ob/ob   mice. Indeed, although both 
  Adr   2 osb  
+/        and   ob/+   mice had normal serum insulin levels, 
  ob/+ ;  Adr   2 osb  
+/        mice displayed a hyperinsulinemia and lower 
blood glucose level after feeding (  Fig. 2, K and L  ). The severity 
of these two abnormalities was only slightly milder than in   
ob/ob   mice (compare with   Fig. 1, B and C  ). At the molecular 
level,   Insulin   expression was elevated to the same degree in   ob/
ob   and   ob/+ ; Adr   2 osb  
+/        mice (  Fig. 2 M  ). 
  To add further credence to the notion that sympathetic 
signaling in osteoblasts contributes to the leptin regulation of 
  Leptin-dependent sympathetic regulation of 
insulin secretion occurs through 
the osteoblasts 
  Although isoproterenol can affect secretion of insulin by isolated 
islets (  Iversen, 1973  ), two reasons led us to test the hypothesis 
that it was also through the osteoblasts that the sympathetic tone, 
under the control of leptin, regulates insulin secretion. One is the 
functional link existing between leptin, sympathetic tone, and 
bone mass (  Takeda et al., 2002  ), and another one is the recently 
uncovered role of osteoblasts in regulating insulin secretion 
(  Lee et al., 2007  ). To test this hypothesis, we deleted Adr   2,  the 
only adrenergic receptor expressed in osteoblasts, from these 
cells (  Adr   2 osb  
   /       mice). 
  Consistent with our hypothesis, serum insulin levels were 
markedly higher in   Adr   2 osb  
   /       mice than in WT mice (  Fig. 2 G   
and Fig. S2, available at http://www.jcb.org/cgi/content/full/
jcb.200809113/DC1). Accordingly, propranolol, a      blocker  act-
ing through Adr    2, increased insulin serum levels in WT but not 
in   Adr   2 osb  
   /       mice (  Fig. 2 H  ). The increase in serum insulin 
levels developed in   Adr   2 osb  
   /       mice in the absence of any evi-
dence of insulin resistance as determined by insulin tolerance test 
(ITT), serum adiponectin level, and   Adiponectin   expression in fat 
  Figure 1.       Leptin regulates insulin secretion in part through the neuronal pathway.   (A) ITT in 2-wk-old   ob/ob   mice. (B and C) Serum insulin and blood 
glucose in   ob/ob   mice. (D) Gene expression in pancreas or islets of 2-wk-old   ob/ob   mice. (E) Quantiﬁ  cation of insulin/Ki67 immunoreactive cells in islets 
of 2-wk-old   ob/ob   mice. (F and G) Serum insulin and blood glucose in adipocyte-deﬁ  cient (adp-def) mice. (H) Gene expression in pancreas or islets of 2-wk-old 
adipocyte-deﬁ  cient mice. (I  –  K) Quantiﬁ  cation of insulin/Ki67 immunoreactive cells in islets,     -cell area, and     -cell mass of 2-wk-old adipocyte-deﬁ  cient 
mice. (L  –  N) Glucose-stimulated insulin secretion by leptin in islets from WT,   ob/ob  , and   L/L   mice. (O) Serum insulin levels in 1-mo-old   Lepr  syn   
    /        mice. Error 
bars indicate mean + SEM. *, P   <   0.05; **, P   <   0.01; P1, newborn; 1W, 1 wk old; 2W, 2 wk old. Control in O indicates   Synapsin-Cre   mice. In L  –  N, the 
concentration of glucose in the culture media is indicated in millimolars.     JCB • VOLUME 183 • NUMBER 7 • 2008  1238
servations indicate that the leptin-dependent sympathetic 
regulation of insulin secretion occurs in part by modulating 
osteocalcin bioactivity. 
  Esp   expression was up-regulated fourfold by isoprotere-
nol in osteoblasts, whereas expression of   Osteocalcin   and of 
other enzymes modifying it was not (  Fig. 3 A  ). Accordingly, 
and although the serum level of total osteocalcin was normal 
(  Fig. 3 B  ), the amount of osteocalcin binding to hydroxy-
apatite (HA) with low affi  nity, i.e., undercarboxylated and 
biologically active (  Lee et al., 2007  ), was increased in both 
  ob/ob  and  Adr   2 osb  
   /      mice ( Fig. 3 C ). Two control experiments 
val  idated this fi  nding. First, when using serum containing only 
uncarboxylated osteocalcin as a negative control, osteocalcin 
eluted in the same fractions as the ones harboring an increased 
content of osteocalcin in   ob/ob   serum (unpublished data). Sec-
ond, the low affi  nity fractions regulated   Insulin   expression in 
isolated islets, whereas the ones binding to HA with high affi  -
nity did not (  Fig. 3 D  ). 
insulin secretion, we performed two other experiments. Long-
term (1 wk) intracerebroventricular (ICV) infusion of 4 ng/h 
leptin decreased glucose-stimulated insulin secretion in WT 
but not in   Adr   2 osb  
   /       mice (  Fig. 2 N  ). We also used a hyper-
glycemic clamp to assess glucose-stimulated insulin secretion 
in vivo. Leptin ICV infusion also decreased circulating insulin 
levels in WT but not   Adr   2 osb  
   /       mice (  Fig. 2, O and P  ). Col-
lectively, these observations identify sympathetic signaling in 
osteoblasts as a signifi  cant mediator of leptin  ’  s regulation of 
insulin secretion. 
  The sympathetic tone in osteoblasts 
inhibits osteocalcin activity 
  How does sympathetic signaling in osteoblasts regulate insu-
lin secretion in      cells? Osteoblasts secrete osteocalcin, a mol-
ecule stimulating     -cell proliferation and   Insulin   expression 
whose biological activity is decreased by the product of the 
  Esp   gene (  Lee et al., 2007  ;   Ferron et al., 2008  ). Multiple ob-
  Figure 2.       Sympathetic signaling in osteoblasts regulates insulin expression and secretion.   (A)   Ucp1   expression in brown fat of   Lepr  syn   
    /        mice. (B and C) 
Serum epinephrine and norepinephrine levels in   Lepr  syn   
    /        mice. (D and E) Serum insulin levels in   ob/ob   and adipocyte-deﬁ  cient (adp-def) mice after daily 
isoproterenol (+ISO), phenylephrine (+Phe), or clonidine (+Clo) injection for 2 wk. (F)   Ucp1   expression in brown fat of   ob/ob   and adipocyte-  deﬁ  cient 
mice after daily isoproterenol injection. (G) Serum insulin levels in 2-wk-old   Adr    2  osb   
    /        mice. (H) Serum insulin levels in WT and   Adr    2  osb   
    /        mice after 
daily propranolol injection for 2 wk. (I and J) Blood glucose levels and gene expression in islets of 2-wk-old   Adr    2  osb   
    /        mice. (K  –  M) Serum insulin, blood 
glucose, and   Insulin   expression in the pancreas of 2-wk-old   ob/+  ;  Adr    2  osb   
+/        mice. (N) Delta insulin after glucose-stimulated insulin secretion in WT 
and   Adr    2  osb   
    /        mice treated with central leptin infusion at 4 ng/h for 1 wk. (O and P) Plasma insulin levels during hyperglycemic clamps in WT and 
  Adr    2  osb   
    /        mice treated with central leptin infusion at 4 ng/h for 1 wk. Error bars indicate mean + SEM. *, P   <   0.05; **, P   <   0.01. Control in A  –  C 
indicates   Synapsin-Cre   mice. Control in G  –  J and M indicates       1(I)Collagen-Cre   mice.     1239 LEPTIN REGULATION OF INSULIN SECRETION   • Hinoi et al. 
augmented glucose-stimulated insulin secretion from isolated 
islets maintained in either low or high glucose concentrations 
(  Fig. 3 G  ). In addition, expression of   Insulin   and   Glucokinase   in 
isolated islets (  Fig. 3 H  ) was induced by osteocalcin in a time- 
and dose-dependent manner. 
  The relevance of osteocalcin in the leptin-dependent 
sympathetic regulation of insulin secretion was also veri-
fi  ed in vivo. First, increasing osteocalcin bioactivity should 
worsen hyperinsulinemia in   ob/ob   mice. To test this hypoth-
esis, we generated   ob/ob   mice lacking   Esp   ( ob/ob ; Esp 
   /      
mice).   Ob/ob ; Esp 
   /       mice were twofold more hyperinsulin-
emic than   ob/ob   mice at 2 wk of age (  Fig. 4 A  ). Remarkably, 
similar abnormalities were observed in   ob/ob   mice lacking only 
  Next, we tested whether osteocalcin regulates insulin secre-
tion directly. In an islets perifusion assay, 0.03 ng/ml uncarboxyl-
ated osteocalcin was a powerful insulin secretagogue (  Fig. 3 E  ) 
with a strong fi  rst phase and a sustained but lower second phase of 
insulin secretion in all experiments performed (  n   = 3). Cytosolic 
Ca 
2+   imaging was also performed on untreated and osteocalcin-
treated WT mouse islets at 3-, 8-, and 16-mM glucose levels. 
30 mM KCl was used as a positive control. At 3 mM glucose, 
osteocalcin initiated a steady increase of basal Ca 
2+  concentration, 
whereas at 8 and 16 mM glucose, osteocalcin notably enhanced 
the cytosolic Ca 
2+   concentration as compared with control un-
treated islets (  n   = 3;   Fig. 3 F   and Fig. S3, available at http://www
.jcb.org/cgi/content/full/jcb.200809113/DC1). Osteocalcin also 
  Figure 3.       Osteocalcin directly regulates insulin secretion in a Ca 
2+  -dependent manner.   (A) Gene expression in isoproterenol (ISO)- or leptin-treated osteo-
blasts. (B and C) Levels of total and uncarboxylated osteocalcin (HA low afﬁ  nity) in   ob/ob   and   Adr    2  osb   
    /        mice. (D)   Insulin   expression by HA afﬁ  nity frac-
tion in islets. (E) Perifusion of WT islets in the presence of 0.03 ng/ml osteocalcin under a 3-mM glucose condition. (F) Intracellular calcium imaging assay 
using WT islets in the presence of osteocalcin under the different concentrations of glucose. (G) Insulin secretion by osteocalcin in WT islets maintained in 
either low or high glucose. (H) Gene expression in osteocalcin-treated islets. Error bars indicate mean + SEM. *, P   <   0.05; **, P   <   0.01. Control in B and 
C indicates       1(I)Collagen-Cre   mice. In G, the concentration of glucose in the culture media is indicated in millimolars.     JCB • VOLUME 183 • NUMBER 7 • 2008  1240
  Glucokinase  , and   Cdk4   was decreased 50  –  100% in   ob/ob ; 
Osteocalcin 
   /       mice compared with   ob/ob   mice, and    -cell 
proliferation was normalized in   ob/ob ; Osteocalcin 
   /       mice 
(  Fig. 4, H and I  ). The similarity of correction of hyperinsulinemia 
in   ob/ob ; Osteocalcin 
   /       mice and in   ob/ob   mice treated with the 
sympathomimetic isoproterenol supports the view that osteo-
calcin is in vivo a signifi  cant mediator of the leptin-dependent 
sympathetic regulation of insulin secretion.   Osteocalcin   inacti-
vation also decreased serum insulin levels by half in adipo  cyte-
defi  cient mice (  Fig. 4 J  ). Collectively, the results presented in 
this study support the hypothesis that the leptin-dependent sym-
pathetic inhibition of insulin secretion occurs in part via the 
osteoblast and acts by modulating osteocalcin activity. 
one allele of   Esp   ( Fig.  4  B ).   Ob/ob ; Esp 
   /       mice also had low 
blood glucose levels and remained signifi  cantly less glucose in-
tolerant than   ob/ob   mice until 8 wk of age, thus illustrating the 
importance of this pathway in adult mouse physiology ( Fig. 4, A, 
C, and D  ). An improved glucose tolerance was demonstrated by 
the ability of a glucose challenge to increase insulin secretion in 
  ob/ob ; Esp 
   /       but not in   ob/ob   mice (  Fig. 4 E  ). Insulin sensiti-
vity, as measured by hyperinsulinemic-euglycemic clamps, was 
similar in   ob/ob ; Esp 
   /       and   ob/ob   mice (Table S1, available at 
http://www.jcb.org/cgi/content/full/jcb.200809113/DC1). 
 Second,   Osteocalcin   inactivation decreased serum insulin 
levels 50% and normalized blood glucose levels in   ob/ob   mice 
(  ob/ob ; Osteocalcin 
   /      ;   Fig. 4, F and G  ). Expression of   Insulin , 
  Figure 4.       Leptin regulates insulin secretion through osteoblasts.   (A) Serum insulin in 2- and 8-wk-old   ob/ob  ;  Esp 
    /        mice. (B) Serum insulin in 2-wk-old 
  ob/ob  ;  Esp 
    /        mice. (C) Blood glucose in 2  –  8-wk-old   ob/ob  ;  Esp 
    /        mice. (D) Glucose tolerance tests in 2-mo-old   ob/ob  ;  Esp 
    /        mice. (E) Serum insulin 
after glucose challenge in 2-mo-old   ob/ob  ;  Esp 
    /        mice. (F and G) Serum insulin and blood glucose in 2-wk-old   ob/ob  ;  Ocn 
    /        mice. (H) Gene expression 
in pancreas or islets of 2-wk-old   ob/ob  ;  Ocn 
    /        mice. (I) Quantiﬁ  cation of insulin/Ki67-positive cell islets of 2-wk-old   ob/ob  ;  Ocn 
    /        mice. (J) Serum insulin 
in 2-wk-old adipocyte-deﬁ  cient;  Ocn 
    /        mice. adp-def, adipocyte deﬁ  cient. (K) In the presence of leptin, sympathetic tone is high; thus,   Esp   expression in 
the osteoblast is high, and osteocalcin bioactivity is low. This contributes to the inhibition of insulin secretion by leptin. Error bars indicate mean + SEM. 
*, P   <   0.05; **, P   <   0.01. 2W, 2 wk old; 4W, 4 wk old; 8W, 8 wk old; SNS, sympathetic nervous system.     1241 LEPTIN REGULATION OF INSULIN SECRETION   • Hinoi et al. 
hand picked under a light microscope and placed into a perifusion cham-
ber (Millipore). A computer-controlled high performance liquid chromatog-
raphy system (625 LC; Waters Corporation) allowed programmable rates 
of ﬂ  ow and concentration of the appropriate solutions held in a 37  °  C 
water bath. Islets were perifused with Krebs bicarbonate buffer to reach 
baseline hormone secretion values before the addition of the appropriate 
secretagogues. Samples were collected at regular intervals with a fraction 
collector (Waters Corporation). 
  Ca 
2+   imaging 
  Cytosolic Ca 
2+   imaging was performed as described previously (  Gao 
et al., 2007  ). Mouse islets cultured for 3  –  4 d in 10 mM glucose were loaded 
with 1 mmol/liter fura 2-AM (Invitrogen) during a 40-min pretreatment at 
37  °  C in Krebs buffer, transferred to the perifusion chamber, and placed on 
the homeothermic platform of an inverted microscope (Axio Observer Z1; 
Carl Zeiss, Inc.). Islets were perfused with Krebs buffer at 37  °  C while various 
treatments were applied. The microscope was used with a 40  ×   oil immersion 
objective. Intracellular Ca 
2+   was determined by the ratio of the excitation 
of fura 2-AM at 334 and 380 nm. Emission was measured at 520 nm with 
a charge-coupled device camera (Attoﬂ  uor; Invitrogen) and calibrated 
using the Ratio Vision software (Attoﬂ  uor; Invitrogen). 
  In vitro glucose-stimulated insulin secretion 
  For assay of insulin release (  Kitamura et al., 2001  ), ﬁ  ve islets were manu-
ally selected, incubated in Krebs-Ringer solution, and stimulated at 37  °  C 
with various concentrations of glucose in the presence or absence of osteo-
calcin for 1 h. The islets were collected by centrifugation, and the super-
natant was assayed for insulin content by ELISA (Crystal Chem). 
  Cell and molecular studies 
  Primary osteoblasts were prepared from calvaria of 5-d-old pups as previ-
ously described (  Takeda et al., 2002  ). Real-time PCR was performed on 
Dnase I  –  treated total RNA converted to cDNA using iTaq SYBR Green Su-
permix with ROX (6-carboxy-X-rhodamine; Bio-Rad Laboratories) on an 
MX3000 instrument;     -actin ampliﬁ  cation was used as an internal refer-
ence for each sample. 
  Biochemistry 
  Serum levels of insulin (Crystal Chem) and c-peptide (Yanaihara Institute) 
were measured using commercial kits. For quantiﬁ  cation of uncarboxyl-
ated levels of osteocalcin, sera were incubated with HA slurry for 1 h. The 
quantity of osteocalcin present in the unbound fraction and in the fractions 
eluted at 0.02 and 1 M sodium phosphate, pH 6.8, was measured by an 
immunoradiometric assay (Immunotopics). 
  Histology 
  Pancreas was ﬁ  xed in 10% neutral formalin, embedded in parafﬁ  n, and 
sectioned at 5   μ  m; sections were stained with hematoxylin and eosin. 
Immunohistochemistry was performed using rabbit antiinsulin (Santa Cruz 
Biotechnology, Inc.) and mouse anti-Ki67 (Vector Laboratories) antibodies. 
    -cell area represents the surface positive for insulin immunostaining di-
vided by the total pancreatic surface.     -cell mass was calculated as 
    -cell area multiplied by pancreatic weight as described previously (  Lee 
et al., 2007  ). 
  Statistical analyses 
  Results are given as means   ±   SEM. Statistical analyses were performed using 
unpaired two-tailed Student  ’  s   t   or analysis of variance tests. 
  Online supplemental material 
  Fig. S1 shows the characterization of   ob/ob   and adipocyte-deﬁ  cient mice. 
Fig. S2 shows the strategy for generation of conditional   Adr    2  -deﬁ  cient 
mice and the characterization of   Adr    2  osb   
    /        mice. Fig. S3 shows the in-
tracellular calcium imaging performed on untreated WT mice islets at dif-
ferent concentrations of glucose. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200809113/DC1. 
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  Our results reveal that leptin inhibits the endocrine func-
tion of the skeleton. Indeed, to a substantial extent, leptin  ’  s in-
hibition of insulin secretion relies on a three-step cascade, 
including (1) leptin  ’  s up-regulation of sympathetic tone, (2) 
sympathetic enhancement of   Esp   expression in osteoblasts, and 
(3) decrease in osteocalcin bioactivity. Osteocalcin acts in this 
context primarily by regulating insulin expression and secre-
tion. These results do not contradict that leptin acts locally on 
     cells to inhibit insulin secretion (  Covey et al., 2006  ;   Morioka 
et al., 2007  ); rather, they reveal an additional pathway whereby 
leptin fulfi  lls this function. Beyond linking two secreted mole-
cules, i.e., leptin and osteocalcin, these observations establish 
that the metabolic connection between osteoblasts and adipo-
cytes is tighter than originally thought (  Karsenty, 2006  ;   Rosen, 
2008  ). This cross talk includes an important functional compo-
nent because osteoblasts mediate a signifi  cant part of one of the 
endocrine functions on adipocytes. This unexpected functional 
relationship between adipocytes, neurons, sympathetic tone, 
and osteoblasts illustrates in vivo the importance of the skeleton 
in the regulation of glucose homeostasis and provides an exam-
ple of how critical the interplay is between multiple organs in 
the establishment and regulation of major physiological func-
tions in vertebrates. 
  Materials and methods 
  Animals, treatments, and surgical procedures 
    Adr    2A 
    /        (Q. Wang, University of Alabama at Birmingham, Birming-
ham, AL),   Osteocalcin 
    /       ,   Esp 
    /       ,   Lepr-ﬂ  ox/ﬂ  ox  , and       1(I)Collagen-Cre   
mice were previously described (  Altman et al., 1999  ;   Dacquin et al., 
2002  ;   Lee et al., 2007  ;   van de Wall et al., 2008  ). Osteoblast-speciﬁ  c 
  Adr    2-  deﬁ  cient (  Adr    2  osb   
    /       ) mice were generated through homologous 
recombination in embryotic stem cells and through the use of       1(I)Collagen-
Cre   mice. B6.V-  Lep 
ob    /J and FVB-Tg(AZIP/F)1Vsn/J mice were purchased 
from The Jackson Laboratory. 3 mg/kg isoproterenol was injected i.p. 
once daily for 2 wk. For ICV infusion, a 28-gauge cannula (brain infusion 
kit II; Alza) was implanted into the third ventricle as previously described, 
infusing human leptin (Sigma-Aldrich) at 4 ng/h for 7 d (  Ducy et al., 
2000  ). The cannula was connected to an osmotic pump (Alza) placed in 
the dorsal subcutaneous space of the animal. Genotyping was performed 
by PCR analysis of genomic DNA. All procedures involving animals were 
approved by the Institutional Animal Care and Use Committee and con-
form to the relevant regulatory standards. 
  Metabolic studies 
  For glucose tolerance tests, 0.625 or 2 g/kg glucose was injected i.p. after 
an overnight fast, and blood glucose was monitored using blood glucose 
strips and the Accu-Check glucometer (Roche) at the indicated times. For 
ITT, mice were injected i.p. with 0.25 or 0.5 U/kg insulin, and blood glu-
cose levels were measured at the indicated times. ITT data are presented 
as a percentage of initial blood glucose concentration. Hyperinsulinemic-
euglycemic clamps and hyperglycemic clamps were performed at the 
Pennsylvania State Diabetes and Obesity Mouse Phenotyping Center. In 
brief,   ob/ob  ,   ob/ob  ;  Esp 
    /       , and WT littermate mice (  n   = 4 for each 
group) were fasted overnight, and a 2-h hyperinsulinemic (2.5 mU/kg/
min)-euglycemic clamp was performed after intravenous administration of 
[3- 
3  H] glucose and 2-deoxy-  D  -[1- 
14  C] glucose as previously described (  Kim 
et al., 2004  ).   Adr    2  osb   
    /        and control mice (  n   = 4 for each group) were 
fasted overnight, and a 2-h hyperglycemic clamp was conducted with a 
variable infusion of 20% glucose to maintain hyperglycemia at     300 mg/dl. 
Blood samples were taken at 10  –  20-min intervals for the measurement of 
plasma insulin levels (  Cho et al., 2007  ). 
  Islet perifusion 
  Islet perifusion was performed as described previously (  Gao et al., 2007  ). 
In brief, islets were isolated from WT mice using standard collagenase di-
gestion followed by puriﬁ  cation through a Ficoll gradient. 100 islets were JCB • VOLUME 183 • NUMBER 7 • 2008  1242
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